BK Virus R-gene Real-time Detection and Quantification Kit (used to measure the viral load of BK virus in whole blood, plasma and urine samples). An in vitro diagnostic medical device (IVD). 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Biomerieux Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2016-RN-01041-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2016-08-05
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Following a customer complaint about difficulties to interpret low viral load in whole blood samples, a biomérieux investigation showed that the sensitivity of the bk virus r-gene of 260 copies/ml (corresponding to 2.41 log10) claimed in the ifu for whole blood was not confirmed. a limit of detection (lod) experiment conducted with whole blood samples has led to a lod value of 1578 copies/ml (corresponding to 3.20 log10).The issue only impacts whole blood samples with a low viral load (260 to 1578 copies/ml), where amplification leads to creeping/flat amplification curves that are difficult to interpret. these problems of interpretation could lead to:- a false negative result,- a delayed result until a new run or a new test is performed.This issue has no impact on negative results or on high positive samples, as the amplification curves are well identified and also, does not impact the test when urine or plasma samples are used.
  • 조치
    bioMérieux is advising users that the Limit of Detection (LOD) is 1578 copies/mL rather than 260 copies/mL for whole blood samples until the root cause is identified and corrected. In addition, bioMérieux is advising that in case of doubt or for attended low viral load samples, testing should be performed on plasma or urine samples instead whole blood samples. Any concerns regarding previously reported results should be discussed with the Laboratory/Medical Director to determine the appropriate course of action. Following the completion of the manufacturer’s investigation, further actions may be undertaken.

Device

  • 모델명 / 제조번호(시리얼번호)
    BK Virus R-gene Real-time Detection and Quantification Kit (used to measure the viral load of BK virus in whole blood, plasma and urine samples). An in vitro diagnostic medical device (IVD).Catalogue Number: 69-013BLot Numbers:1003909940, expiry 12-03-20171004754140, expiry 04-02-20181004764070, expiry 04-02-2018ARTG Number: 211361
  • Manufacturer

Manufacturer